Microvesicle-Mediated Transfer of DNA Methyltransferase Proteins Results in Recipient Cell Immunosuppression
Journal of Surgical Research · 2023-03 · 283 · 368-376
DOI: 10.1016/j.jss.2022.10.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2023-03. Verfasst von Ryan Harkless und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ohio State University Wexner Medical Center, Department of Surgery, Columbus, Ohio. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Sepsis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, National Institutes of Health.
Abstract (Originalsprache)
INTRODUCTION: Patients with sepsis exhibit significant, persistent immunologic dysfunction. Evidence supports the hypothesis that epigenetic regulation of key cytokines plays an important role in this dysfunction. In sepsis, circulating microvesicles (MVs) containing elevated levels of DNA methyltransferase (DNMT) mRNA cause gene methylation and silencing in recipient cells. We sought to examine the functional role of MV DNMT proteins in this immunologic dysfunction. METHODS: In total, 33 patients were enrolled within 24 h of sepsis diagnosis (23 sepsis, 10 critically ill controls). Blood and MVs were collected on days 1, 3, and 5 of sepsis, and protein was isolated from the MVs. Levels of DNMT protein and activity were quantified. MVs were produced in vitro by stimulating naïve monocytes with lipopolysaccharide. Methylation was assessed using bisulfate site-specific qualitative real-time polymerase chain reaction. RESULTS: The size of MVs in the patients with sepsis decreased from days 1 to 5 compared to the control group. Circulating MVs contained significantly higher levels of DNMT 1 and 3A, protein. We recapitulated the production of these DNMT-containing MVs in vitro by treating monocytes with lipopolysaccharide. We found that exposing naïve monocytes to these MVs resulted in increased promoter methylation of tumor necrosis factor alpha. CONCLUSIONS: An analysis of the isolated MVs revealed higher levels of DNMT proteins in septic patients than those in nonseptic patients. Exposing naïve monocytes to DNMT-containing MVs produced in vitro resulted in hypermethylation of tumor necrosis factor alpha, a key cytokine implicated in postsepsis immunosuppression. These results suggest that DNMT-containing MVs cause epigenetic changes in recipient cells. This study highlights a novel role for MVs in the immune dysfunction of patients with sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ohio State University Wexner Medical Center, Department of Surgery, Columbus, Ohio.
- Indiana Center for Regenerative Medicine & Engineering, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
- Ohio State University Wexner Medical Center, Department of Surgery, Columbus, Ohio. Electronic address: Jon.wisler@osumc.edu.
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Harkless, R., Singh, K., Christman, J., McCarty, A., Sen, C., Jalilvand, A., & Wisler, J. (2023). Microvesicle-Mediated Transfer of DNA Methyltransferase Proteins Results in Recipient Cell Immunosuppression. Journal of Surgical Research, 283, 368-376. https://doi.org/10.1016/j.jss.2022.10.030
Vancouver
Harkless R, Singh K, Christman J, McCarty A, Sen C, Jalilvand A, et al. Microvesicle-Mediated Transfer of DNA Methyltransferase Proteins Results in Recipient Cell Immunosuppression. Journal of Surgical Research. 2023;283:368-376. doi:10.1016/j.jss.2022.10.030
BibTeX
@article{Harkless2023,
author = {Harkless, Ryan and Singh, Kanhaiya and Christman, John and McCarty, Adara and Sen, Chandan and Jalilvand, Anahita and Wisler, Jon},
title = {Microvesicle-Mediated Transfer of DNA Methyltransferase Proteins Results in Recipient Cell Immunosuppression},
journal = {Journal of Surgical Research},
year = {2023},
volume = {283},
pages = {368--376},
doi = {10.1016/j.jss.2022.10.030}
}
EUVIMED